BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neocentromeres
,
Doxorubicin
,
rs6983267
,
IGF1
,
T cell receptor signaling pathway
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
EZH2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Hematopoietic stem cell of bone marrow
Granulocyte-macrophage progenitor cell of bone marrow
T Lymphocyte (regulatory) of peripheral blood
Dendritic (plasmacytoid) cell
Testes
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Antiphospholipid syndrome
Legionella infection
Toxoplasmosis
Vesicular stomatitis Indiana virus disease
Injury of lung
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Herceptin
Nonoxynol-9
Adenovirus E1A Proteins
tri-(2-ethylhexyl)trimellitate
Granulocyte-Macrophage Colony-Stimulating Factor
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Mir34c
L1TD1
ZIC3
CD46
EZH2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Regulation of EZH2 protein stability: new mechanisms, roles in tumorigenesis, and roads to the clini…
Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2).
EZH2 immunoexpression in pleomorphic adenoma and adenoid cystic carcinoma and clinicopathological fe…
EZH2 as a potential therapeutic target for gastrointestinal cancers.
EZH2-mediated development of therapeutic resistance in cancer.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negativ…
Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma With…
EZH2 Inhibitor, Tazemetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ